Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Figg

Showing results (51-60 of 638) with videos related to

Pageof 64
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Thalidomide metabolism by the CYP2C subfamilyYuichi Ando, Eiichi Fuse, William D Figg
Cancer Biology & Therapy|September 14, 2006
Randomized discontinuation trial of sorafenib (BAY 43-9006)Lokesh Jain, Jürgen Venitz, William D Figg
Cancer Biology & Therapy|July 22, 2014
Potential novel role of bevacizumab in glioblastoma and cervical cancerAndrew K L Goey, William D Figg
Cancer Biology & Therapy|December 24, 2014
Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancerWilliam D Figg, Katherine Cook, Robert Clarke
Cancer Biology & Therapy|June 26, 2026
Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapyAllison Staton, Melissa Abel, William D Figg
Cancer Biology & Therapy|January 22, 2005
Upregulation of endogenous angiogenesis inhibitors: a mechanism of action of metronomic chemotherapySylvia S W Ng, William D Figg
Cancer Biology & Therapy|May 6, 2017
Cellular identity crisis: Antiandrogen resistance by lineage plasticityDaniel Tuerff, Tristan Sissung, William D Figg
Biomedical Chromatography : BMC|September 14, 2002
A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasmaSuoping Zhai, Edward Sausville, William D Figg
Pharmacological Research|January 17, 2016
UGT genotyping in belinostat dosingAndrew K L Goey, William D Figg
Cancer Biology & Therapy|February 28, 2022
Lutetium-177-PSMA-617: A Vision of the FutureElias Chandran, William D Figg, Ravi Madan
Pageof 64

Showing results (51-60 of 638) with videos related to

Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Thalidomide metabolism by the CYP2C subfamilyYuichi Ando, Eiichi Fuse, William D Figg
Cancer Biology & Therapy|September 14, 2006
Randomized discontinuation trial of sorafenib (BAY 43-9006)Lokesh Jain, Jürgen Venitz, William D Figg
Cancer Biology & Therapy|July 22, 2014
Potential novel role of bevacizumab in glioblastoma and cervical cancerAndrew K L Goey, William D Figg
Cancer Biology & Therapy|December 24, 2014
Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancerWilliam D Figg, Katherine Cook, Robert Clarke
Cancer Biology & Therapy|June 26, 2026
Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapyAllison Staton, Melissa Abel, William D Figg
Cancer Biology & Therapy|January 22, 2005
Upregulation of endogenous angiogenesis inhibitors: a mechanism of action of metronomic chemotherapySylvia S W Ng, William D Figg
Cancer Biology & Therapy|May 6, 2017
Cellular identity crisis: Antiandrogen resistance by lineage plasticityDaniel Tuerff, Tristan Sissung, William D Figg
Biomedical Chromatography : BMC|September 14, 2002
A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasmaSuoping Zhai, Edward Sausville, William D Figg
Pharmacological Research|January 17, 2016
UGT genotyping in belinostat dosingAndrew K L Goey, William D Figg
Cancer Biology & Therapy|February 28, 2022
Lutetium-177-PSMA-617: A Vision of the FutureElias Chandran, William D Figg, Ravi Madan
Pageof 64